Figure 2.
Kaplan-Meier estimates of probabilities of progression-free survival, according to baseline circulating tumor cell count in patients with newly diagnosed inflammatory breast cancer.
Kaplan-Meier estimates of probabilities of progression-free survival, according to baseline circulating tumor cell count in patients with newly diagnosed inflammatory breast cancer.